The ATLAS Community Health Initiative aims to recruit 150,000 patients across the health system with the goal of creating California's largest genomic resource that can be used for translational medicine. A large-scale collection of diverse patient blood, saliva, and tissue samples are genotyped for researchers and clinicians to analyze the data with clinical, environmental, and life style information and deliver the best care to our patients. Patients’ participation is voluntary and their privacy is protected by de-identifying the samples.
UCLA Health is committed to help patients make an informed decision about participating in ATLAS. UCLA Patients who have not already completed the Universal Consent may receive a participation link on their mobile device when notified of their upcoming appointment. In addition, patients who visit any of our participating locations can complete the Universal Consent on an ipad offered upon check-in. As the bio-samples become available for patients who have opted-in to participate in ATLAS, the UCLA Biobank picks up samples and de-identifies them for DNA extraction and genotyping.